The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of sintilimab plus pemetrexed and platinum (SPP) according to stage of disease in patients (pts) with locally advanced or metastatic nonsquamous NSCLC (AMnsqNSCLC) in the phase 3 ORIENT-11 study.
 
Yunpeng Yang
No Relationships to Disclose
 
Zhehai Wang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Jian Fang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Qitao Yu
No Relationships to Disclose
 
Baohui Han
No Relationships to Disclose
 
Shundong Cang
No Relationships to Disclose
 
Gongyan Chen
No Relationships to Disclose
 
Xiaodong Mei
No Relationships to Disclose
 
Zhixiong Yang
No Relationships to Disclose
 
Victoria Jennifer Stefaniak
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
David Raymond Ferry
Employment - Lilly
Leadership - Lilly
Stock and Other Ownership Interests - Lilly
 
Yumin Zhao
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Shuyan Wang
Employment - Innovent Biologics
 
Yan Wang
Employment - Innovent Biologics
 
Luyao Sun
Employment - Innovent Biologics
 
Li Zhang
Consulting or Advisory Role - AstraZeneca; Innovent Biologics
Speakers' Bureau - AstraZeneca; BeiGene; HenRui; Innovent Biologics; Roche China
Research Funding - Akeso Biopharma (Inst); AstraZeneca (Inst); BMS (Inst); Chia Tai Tianqing Pharmaceutical Group (Inst); Junshi Pharmaceuticals (Inst); QiLu Pharmaceutical (Inst)